Interview with Klaus Dugi, Grainne Quinn and Wolfram Nothaft As the influence and voice of medical affairs increases within pharmaceutical companies, the pos...

Words by James Coker The topic of the pharmaceutical industry’s relationship with healthcare thought leaders has not escaped its share of controversy and eve...

Words by James Coker Sky-rocketing drug prices has emerged as one of the biggest healthcare issues currently threatening access to treatments worldwide; sadl...

Words by Kirstie Turner Once upon a time, there was an industry cursed with a negative reputation and a perceived lack of scientific integrity. Pharma’s fair...

Words by James Coker There has been an increasing focus on the development of precision medicine in the pharmaceutical industry over recent years. In this ar...

Words by James Coker Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some ti...

Words by Louise Rogers As the responsibilities of medical affairs continue to mushroom, so too do the grey clouds of misunderstanding, casting a shadow on th...

Words by James Coker The dynamics of leadership are changing. The traditional image of a leader, reminiscent of a 19th Century naval Captain giving orders to...

Words by Kirstie Turner The language around regulations and safety labels can leave patients feeling confounded; but a simple ‘Eat Me’ tag is not enough. Reg...

Words by James Coker “Please sir, I want some more.” That immortal line from Charles Dickens’ classic novel Oliver Twist is just as relevant for considering ...

Words by Kirstie Turner “We have to remember that medical affairs is about people; it is about emotions and medical conditions. It is understanding the human...

Words by James Coker That pharma must undergo a reformation, moving to a whole new model of technological innovation, patient centricity, and prevention stra...

Words by James Coker The age of the internet has ushered in a desire for quick and easy access to information. Healthcare is no exception; for instance, it h...

Words by Louise Rogers “Leadership is about making others better as a result of your presence and making sure that impact lasts in your absence.” This eloque...

Words by Danny Buckland Patient power is emerging as a saviour of costly clinical trials that get slowed by the scientific process and tangled in regulatory ...

Words by Martin Barrow Pharma is investing heavily in MA. There is a determination to create highly-skilled teams of externally-facing medical professionals ...

There is a saying that good chess players will think five moves ahead and great chess players only one, but it is always the right move. The recent blossomin...

Words by Louise Rogers. Quality over quantity is a concept commonly associated with food, used to justify buying that palm-size cut of premium rib-eye, where...

Words by Louise Rogers. The co-ordinated union of medical affairs and marketing has been in the pipeline ever since the changing regulatory landscape mandate...

Words by Martin Barrow. The age of big data is redefining the role of medical affairs in the pharmaceutical industry. Formerly regarded as technical product ...